Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Plasma norepinephrine and mortality
Jay N. Cohn
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
52
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Plasma norepinephrine and mortality'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Norepinephrine Levels
100%
Heart Failure
50%
Sympathetic Nervous System
50%
Disease Progression
25%
Poor Prognosis
25%
Physiologic
25%
Left Ventricular Dysfunction
25%
Exercise Capacity
25%
Symptomatic Heart Failure
25%
Life Expectancy
25%
Enalapril
25%
Ejection Fraction
25%
Clinical Variables
25%
Course of Illness
25%
Hydralazine
25%
Isosorbide Dinitrate
25%
Vasodilator Therapy
25%
Neurohormonal Activation
25%
Asymptomatic Left Ventricular Dysfunction
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Nursing and Health Professions
Noradrenalin Blood Level
100%
Noradrenalin Level
66%
Congestive Heart Failure
50%
Heart Left Ventricle Failure
33%
Diseases
33%
Heart Ejection Fraction
16%
Life Expectancy
16%
Isosorbide Dinitrate/Hydralazine
16%
Enalapril
16%
Enzyme Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Noradrenalin
100%
Congestive Heart Failure
50%
Heart Left Ventricle Failure
33%
Diseases
33%
Hydralazine
16%
Life Expectancy
16%
Enalapril
16%
Isosorbide Dinitrate
16%
Enzyme Inhibitor
16%
Neuroscience
Norepinephrine
100%
Blood Plasma
100%
Sympathetic Nervous System
33%
Vasodilators
16%
Isosorbide Dinitrate/Hydralazine
16%
Enzyme Inhibitor
16%
Enalapril
16%
Biochemistry, Genetics and Molecular Biology
Noradrenalin Blood Level
100%
Noradrenalin Level
66%
Heart Ventricle Function
33%
Enzyme Inhibitor
16%
Heart Ejection Fraction
16%
Life Expectancy
16%
Hydralazine
16%